Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT07006207
Starting soon Not applicable

Brain Olfactory Pathways in Prader-Willi Syndrome

NCT07006207 · tracked via the Priya Life Science France tracker
Sponsor
University Hospital, Toulouse
Phase
Not applicable
Started
2025-06-23
Last updated
2025-06-05

Condition(s) studied

Prader-Willi Syndrome

Investigational drug(s) / intervention(s)

olfactory stimulationfunctional MRI

olfactory stimulation: the patients have a sniff-test

functional MRI: patients have a an f MRI

Study summary

Studying the cerebral activity of children with Prader-Willi Syndrom (PWS) when the study propose to them nasal activations.

Eligibility

Sex
ALL
Min age
5 Years
Max age
7 Years
Healthy volunteers
No
Inclusion Criteria: * child with a genetically confirmed diagnosis of PWS and for whom the genetic subtype (deletion or non deletion) has been identified * Child aged between 5 and 7 years * Child with a planned hospitalization at the Toulouse reference center for PWS Exclusion Criteria: * Presence of a contraindication to MRI * Allergy to any of the fragrances used in the olfactory test * Presence of an ENT infection such as rhinitis or sinusitis on the day of inclusion * Reported anosmia * Administrative problems.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University Hospital Toulouse France

More University Hospital, Toulouse trials in France

Adapted Physical Activity for Children Treated With Cancer and Insulin Sensitivity Recruiting
Neurofeedback-EEG Rehabilitation Protocol on Motor Recovery in the Subacute Phase Post-stroke (CUSTOM-NF-STROKE) Recruiting
Molecular Analysis of Endoscopic Cytology Samples Supernatant in Pulmonary Nodules Recruiting
Periodontal Microbiota of Patients Candidates for Bariatric Surgery With Body Mass Index Greater Than 30 Recruiting
Effects of an Intensive Rhythmic Dance Program on Learning Skills in Children With Cerebral Palsy Recruiting

Other trials for the same condition

Register of Patients With Prader-Willi Syndrome Recruiting
A Study of Pitolisant in Patients With Prader-Willi Syndrome Recruiting
Effects of Transcutaneous Vagus Nerve Stimulation on Emotion Regulation and Executive Functioning in Prader-Willi Syndrome Recruiting
Autistic Symptomatology and Sensory Profile in Children With Prader-Willi Syndrome Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07006207 on ClinicalTrials.gov ↗ ← All trials in France